Skip to main content


This case study explores how real-world neurologist and investigator insights helped optimize Phase III CNS trial execution. Learn how AI-powered intelligence improved recruitment efficiency, minimized patient dropout risks, reduced delays by 4–6 months, and supported more effective clinical trial site selection strategies in biopharma research.